Á. Bulnes-Ramos

发表

Immunological features beyond CD4/CD8 ratio values in older individuals

M. Leal, I. Herrero-Fernández, I. Rosado-Sánchez, 2021, Aging.

TRIM5α Restriction of HIV-1-N74D Viruses in Lymphocytes Is Caused by a Loss of Cyclophilin A Protection

J. Hultquist, A. Selyutina, F. Diaz-Griffero, 2020, bioRxiv.

Influenza vaccination during the first 6 months after solid organ transplantation is efficacious and safe.

E. Cordero, P. Muñoz, J. Torre-Cisneros, 2015, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Effect of Influenza Vaccination Inducing Antibody Mediated Rejection in Solid Organ Transplant Recipients

E. Cordero, P. Muñoz, J. Torre-Cisneros, 2020, Frontiers in Immunology.

Nucleic acid binding by SAMHD1 contributes to the antiretroviral activity and is enhanced by the GpsN modification

Alexander B. Taylor, D. Ivanov, Baek Kim, 2021, Nature Communications.

Factors associated with the humoral response after three doses of COVID-19 vaccination in kidney transplant recipients

M. M. Pozo-Balado, C. Lozano, Y. Pacheco, 2023, Frontiers in Immunology.

Cyclophilin A Prevents HIV-1 Restriction in Lymphocytes by Blocking Human TRIM5α Binding to the viral Core

N. Krogan, J. Hiatt, J. Hultquist, 2019, bioRxiv.

Two Doses of Inactivated Influenza Vaccine Improve Immune Response in Solid Organ Transplant Recipients: Results of TRANSGRIPE 1–2, a Randomized Controlled Clinical Trial

E. Cordero, P. Muñoz, J. Torre-Cisneros, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Dysregulation of iron metabolism modulators in virologically suppressed HIV-infected patients

M. Leal, M. M. Pozo-Balado, Y. Pacheco, 2022, Frontiers in Immunology.

Longitudinal age differences in humoral responses to the COVID-19 vaccine in the elderly are lost after the third dose

M. Leal, M. M. Pozo-Balado, Y. Pacheco, 2022, Journal of Infection.

Applying lessons learned from cytomegalovirus infection in transplant patients to vaccine design.

D. Navarro, M. McConnell, Á. Bulnes-Ramos, 2016, Drug discovery today.

Binding of host factors to stabilized HIV-1 capsid tubes.

A. Selyutina, F. Diaz-Griffero, Á. Bulnes-Ramos, 2018, Virology.

Partial restoration of gut‐mucosal dysbiosis in late‐treated HIV‐infected subjects with CD4 T‐cell recovery

M. Leal, I. Herrero-Fernández, I. Rosado-Sánchez, 2022, Clinical and translational medicine.

Higher plasma levels of thymosin-α1 are associated with a lower waning of humoral response after COVID-19 vaccination: an eight months follow-up study in a nursing home

M. Leal, M. M. Pozo-Balado, C. Lozano, 2023, Immunity & Ageing.

Immunogenicity and safety of influenza vaccination in patients with juvenile idiopathic arthritis on biological therapy using the microneutralization assay

O. Neth, L. Fernández-Silveira, Á. Bulnes-Ramos, 2017, Pediatric Rheumatology.

1 1 TRIM 5 α restriction of HIV-1N 74 D viruses in lymphocytes is 2 caused by a loss of cyclophilin A protection 3 4 5

J. Hultquist, A. Selyutina, F. Diaz-Griffero, 2022 .

Cyclophilin A Prevents HIV-1 Restriction in Lymphocytes by Blocking Human TRIM5α Binding to the Viral Core.

N. Krogan, J. Hiatt, J. Hultquist, 2020, Cell reports.